TRK inhibitor activity and resistance in TRK fusion-positive cancers in adults

Harada, G; Drilon, A

Drilon, A (通讯作者)，Mem Sloan Kettering Canc Ctr, Dept Med, 885 2nd Ave, New York, NY 10017 USA.;Drilon, A (通讯作者)，Weill Cornell Med Coll, Dept Med, 1300 York Ave, New York, NY 10065 USA.

CANCER GENETICS, 2022; 264 (): 33

Abstract

NTRK fusions drive oncogenesis in a variety of adult cancers. The approval of the first-generation TRK inhibitors, larotrectinib and entrectinib, for ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索